ScholarIQanswers from OpenAlex
Institut Sainte Catherine
InstitutionResearch output, impact & collaborations
Institut Sainte Catherine is a institution indexed in ScholarIQ from OpenAlex.
What is known about Institut Sainte Catherine?
ScholarIQrecord summary
Institut Sainte Catherine is a research organisation in Avignon, FR. OpenAlex records 1,294 works and 63,278 citations for it. 224 researchers list it as their most recent affiliation.
How many works does Institut Sainte Catherine have?
ScholarIQindexed works
Institut Sainte Catherine has 1,294 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Institut Sainte Catherine have?
ScholarIQcitation count
Institut Sainte Catherine has 63,278 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Institut Sainte Catherine?
ScholarIQresearcher count
Institut Sainte Catherine has 224 researchers in the ScholarIQ index.
What is the average h-index at Institut Sainte Catherine?
ScholarIQavg h-index
Institut Sainte Catherine has an average h-index of 49 in OpenAlex.
What is the ROR of Institut Sainte Catherine?
ScholarIQror
The ROR for Institut Sainte Catherine is on the source record.
What is the OpenAlex record for Institut Sainte Catherine?
ScholarIQopenalex
The OpenAlex for Institut Sainte Catherine is on the source record.
Who are the most-cited researchers behind Institut Sainte Catherine?
ScholarIQtop researchers by citations
What are the most-cited papers on Institut Sainte Catherine?
ScholarIQmost cited works
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade, I. Martel-Laffay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, Guy de La Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, M.-A. Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, C. Montoto-Grillot, Thierry Conroy
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade, Isabelle Martel‐Lafay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, Guy de La Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, Jean‐François Seitz, Laurent Bedenne, Béata Juzyna, Thierry Conroy
Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study
Benoist Chibaudel, Frédérique Maindrault‐Gœbel, Gérard Lledo, Laurent Mineur, Thierry André, Mostepha Bennamoun, May Mabro, Pascal Artru, Élisabeth Carola, M. Flesch, Olivier Dupuis, Philippe Colin, Annette K. Larsen, Pauline Afchain, Christophe Tournigand, Christophe Louvet, Aimery de Gramont
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
Thierry André, Déwi Vernerey, Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, Roger Faroux, Serge Fratté, Marine Hug de Larauze, Sophie Paget‐Bailly, Benoist Chibaudel, Jérémie Bez, Jérôme Dauba, Christophe Louvet, Céline Lepère, Olivier Dupuis, Y. Bécouarn, May Mabro, Joëlle Egreteau, Olivier Bouché, G. Deplanque, Marc Ychou, Marie Pierre Galais, François Ghiringhelli, Louis Marie Dourthe, Jean‐Baptiste Bachet, Ahmed Khalil, Franck Bonnetain, Aimery de Gramont, Julien Taı̈eb, for PRODIGE investigators, GERCOR, Fédération Française de Cancérologie Digestive, and UNICANCER
How much of the research on Institut Sainte Catherine is open access?
ScholarIQopen access share
25%OPEN ACCESS